• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米生物技术工程血红蛋白和血红蛋白纳米胶囊的血液替代。

Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.

机构信息

Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, McGill University, Montreal, Quebec, Canada H3G1Y6.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jul-Aug;2(4):418-30. doi: 10.1002/wnan.95.

DOI:10.1002/wnan.95
PMID:20564467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3518484/
Abstract

Unlike donor red blood cells (RBCs), blood substitutes can be treated to remove infective agents and can be used on the spot or in the ambulance in emergency without the time-consuming typing and cross-matching. Donor RBC requires storage at 4 degrees and is only good for 42 days, but blood substitutes can be stored for much longer time. For example, a bovine polyhemoglobin (PolyHb) can be stored at room temperature for more than 1 year. It has been shown as far back as 1957 that artificial RBC can be prepared with ultrathin polymer membranes of nanodimension thickness. To increase the circulation time, the first-generation engineered hemoglobin (Hb) is formed by using glutaraldehyde to crosslink Hb into soluble nanodimension PolyHb that has been tested clinically in patients. Further extension includes conjugated Hb, intramolecularly crosslinked Hb and recombinant Hb. For certain clinical uses, in addition to engineered Hb, we also need antioxidants to remove oxygen radicals to prevent injury from ischemia reperfusion. Thus, we use nanobiotechnology to prepare second-generation engineered Hb by assembling Hb together with superoxide dismutase (SOD) and catalase (CAT) to form a nanodimension soluble complex of polyhemoglobin (PolyHb)-CAT-SOD. A third generation system is to prepare nanodimension complete artificial RBCs that can circulate for sufficient length of time after infusion. One approach uses lipid vesicles to encapsulate hemoglobin (Hb). Another approach is to use biodegradable polymer-like polylactic acid or a copolymer of polyethylene glycol-polylactide (PEG-PLA) to form the membrane of nanodimension complete artificial RBC (www.artcell.mcgill.ca).

摘要

与供体红细胞(RBC)不同,血液替代品可以经过处理以去除感染性物质,并且可以在现场或救护车上使用,而无需耗时的血型鉴定和交叉配型。供体 RBC 需要在 4 摄氏度下储存,并且仅在 42 天内有效,但血液替代品可以储存更长的时间。例如,牛血红蛋白(PolyHb)可以在室温下储存超过 1 年。早在 1957 年就已经证明,可以使用具有纳米级厚度的超薄聚合物膜来制备人工 RBC。为了增加循环时间,第一代工程血红蛋白(Hb)是通过使用戊二醛将 Hb 交联成可溶的纳米级 PolyHb 制成的,这种 PolyHb 已经在患者中进行了临床测试。进一步的延伸包括共轭 Hb、分子内交联 Hb 和重组 Hb。对于某些临床用途,除了工程化 Hb,我们还需要抗氧化剂来清除氧自由基,以防止缺血再灌注损伤。因此,我们使用纳米生物技术通过将 Hb 与超氧化物歧化酶(SOD)和过氧化氢酶(CAT)组装在一起来制备第二代工程化 Hb,从而形成聚血红蛋白(PolyHb)-CAT-SOD 的纳米级可溶性复合物。第三代系统是制备纳米级完整的人工 RBC,在输注后可以循环足够长的时间。一种方法是使用脂质体来包裹血红蛋白(Hb)。另一种方法是使用可生物降解的聚合物样聚乳酸或聚乙二醇-聚乳酸共聚物(PEG-PLA)来形成纳米级完整人工 RBC 的膜(www.artcell.mcgill.ca)。

相似文献

1
Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.纳米生物技术工程血红蛋白和血红蛋白纳米胶囊的血液替代。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jul-Aug;2(4):418-30. doi: 10.1002/wnan.95.
2
Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.聚[血红蛋白-超氧化物歧化酶-过氧化氢酶-碳酸酐酶]溶液形式或冻干形式在-80°C、4°C、25°C和37°C储存期间或70°C巴氏灭菌时的温度稳定性。
Artif Cells Nanomed Biotechnol. 2016;44(1):41-7. doi: 10.3109/21691401.2015.1110871. Epub 2015 Nov 27.
3
Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation.聚乙二醇-聚丙交酯纳米尺寸人工红细胞在维持全身血红蛋白水平及预防高铁血红蛋白形成方面的分析
Artif Cells Blood Substit Immobil Biotechnol. 2003 Aug;31(3):231-47. doi: 10.1081/bio-120023155.
4
A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.一种新型纳米生物治疗剂聚[血红蛋白-超氧化物歧化酶-过氧化氢酶-碳酸酐酶],无心脏毒性,用于复苏失血量达 2/3 全血容量、持续 90 分钟的严重失血性休克大鼠模型。
Artif Cells Nanomed Biotechnol. 2015 Feb;43(1):1-9. doi: 10.3109/21691401.2014.964554. Epub 2014 Oct 9.
5
Nanobiotechnology for hemoglobin-based blood substitutes.用于基于血红蛋白的血液替代品的纳米生物技术。
Crit Care Clin. 2009 Apr;25(2):373-82, Table of Contents. doi: 10.1016/j.ccc.2008.12.006.
6
Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.新型纳米人工红细胞,作为 O2 和 CO2 载体,具有增强的抗氧化活性:PLA-PEG 纳米包裹 PolySFHb-超氧化物歧化酶-过氧化氢酶-碳酸酐酶。
Artif Cells Nanomed Biotechnol. 2013 Aug;41(4):232-9. doi: 10.3109/21691401.2012.751180. Epub 2013 Jan 22.
7
From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.从人工红细胞、氧载体和氧治疗剂到人工细胞、纳米医学等等。
Artif Cells Blood Substit Immobil Biotechnol. 2012 Jun;40(3):197-9. doi: 10.3109/10731199.2012.662408. Epub 2012 Mar 13.
8
Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.本实验室对血红蛋白和酶进行的纳米生物技术修饰。
Biochim Biophys Acta. 2008 Oct;1784(10):1435-40. doi: 10.1016/j.bbapap.2008.05.006. Epub 2008 Jun 17.
9
Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.多聚血红蛋白-超氧化物歧化酶-过氧化氢酶-碳酸酐酶:一种基于生物技术的新型血液替代品,可运输氧气和二氧化碳,并具有抗氧化作用。
Artif Cells Blood Substit Immobil Biotechnol. 2011 Jun;39(3):127-36. doi: 10.3109/10731199.2011.581052.
10
Hemoglobin-based red blood cell substitutes.基于血红蛋白的红细胞替代物。
Artif Organs. 2004 Sep;28(9):789-94. doi: 10.1111/j.1525-1594.2004.07394.x.

引用本文的文献

1
Red blood cells-derived components as biomimetic functional materials: Matching versatile delivery strategies based on structure and function.红细胞衍生成分作为仿生功能材料:基于结构与功能匹配的通用递送策略
Bioact Mater. 2025 Feb 13;47:481-501. doi: 10.1016/j.bioactmat.2025.01.021. eCollection 2025 May.
2
Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases.使用人工氧载体进行氧的治疗性输送证明了治疗多种疾病的可能性。
J Nanobiotechnology. 2025 Jan 18;23(1):25. doi: 10.1186/s12951-024-03060-9.
3
Artificial blood for therapeutic and laboratory usage: Where do we stand?

本文引用的文献

1
Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.提取红细胞酶以制备多聚血红蛋白-过氧化氢酶-超氧化物歧化酶。
Artif Cells Blood Substit Immobil Biotechnol. 2009;37(2):69-77. doi: 10.1080/10731190902742240. Epub 2009 Feb 18.
2
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.在无法获得血液时使用人聚合血红蛋白治疗失血性休克:美国多中心试验
J Am Coll Surg. 2009 Jan;208(1):1-13. doi: 10.1016/j.jamcollsurg.2008.09.023. Epub 2008 Nov 7.
3
Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells.
用于治疗和实验室用途的人造血液:我们目前的进展如何?
Biomicrofluidics. 2024 Sep 25;18(5):051505. doi: 10.1063/5.0186931. eCollection 2024 Sep.
4
Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: current status and future perspectives.基于纳米材料的血红蛋白氧载体,重点是脂质体和纳米胶囊,用于生物医学应用:现状和未来展望。
J Nanobiotechnology. 2024 Jun 16;22(1):336. doi: 10.1186/s12951-024-02606-1.
5
The Protection of Enzyme Activity for the Preparation of Humanized Polymerized Hemoglobin-Superoxide Dismutase-Catalase-Carbonic Anhydrase.用于制备人源化聚合血红蛋白-超氧化物歧化酶-过氧化氢酶-碳酸酐酶的酶活性保护。
Dokl Biochem Biophys. 2024 Jun;516(1):73-82. doi: 10.1134/S1607672923600483. Epub 2024 Mar 27.
6
Tracking Research on Hemoglobin-Based Oxygen Carriers: A Scientometric Analysis and In-Depth Review.追踪血红蛋白基氧载体的研究:一项科学计量分析和深入综述。
Drug Des Devel Ther. 2023 Aug 24;17:2549-2571. doi: 10.2147/DDDT.S422770. eCollection 2023.
7
Blood substitutes: Basic science, translational studies and clinical trials.血液替代品:基础科学、转化研究与临床试验
Front Med Technol. 2022 Aug 18;4:989829. doi: 10.3389/fmedt.2022.989829. eCollection 2022.
8
Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules.血红蛋白类氧载体:最新研究进展和新型分子。
Shock. 2019 Oct;52(1S Suppl 1):70-83. doi: 10.1097/SHK.0000000000001009.
9
Bio-inspired nanomedicine strategies for artificial blood components.仿生纳米医学策略用于人工血液成分。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6). doi: 10.1002/wnan.1464. Epub 2017 Mar 15.
10
Extraction of Phospholipids from Human Erythrocyte Membranes by Hemoglobin Oxidation Products.血红蛋白氧化产物从人红细胞膜中提取磷脂
J Membr Biol. 2016 Jun;249(3):305-17. doi: 10.1007/s00232-016-9869-2. Epub 2016 Jan 13.
聚乙二醇-聚乳酸纳米人工红细胞33% 高剂量负载后对大鼠肝脏和脾脏组织学及功能的长期影响。
Artif Cells Blood Substit Immobil Biotechnol. 2008;36(6):513-24. doi: 10.1080/10731190802554224. Epub 2008 Dec 9.
4
Effects of PEG-PLA-nano artificial cells containing hemoglobin on kidney function and renal histology in rats.含血红蛋白的聚乙二醇-聚乳酸纳米人工细胞对大鼠肾功能和肾脏组织学的影响。
Artif Cells Blood Substit Immobil Biotechnol. 2008;36(5):421-30. doi: 10.1080/10731190802369763.
5
Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.本实验室对血红蛋白和酶进行的纳米生物技术修饰。
Biochim Biophys Acta. 2008 Oct;1784(10):1435-40. doi: 10.1016/j.bbapap.2008.05.006. Epub 2008 Jun 17.
6
HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.HBOC-201作为输血替代品:在择期骨科手术多中心III期试验中的疗效和安全性评估
J Trauma. 2008 Jun;64(6):1484-97. doi: 10.1097/TA.0b013e318173a93f.
7
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.基于无细胞血红蛋白的血液替代品与心肌梗死和死亡风险:一项荟萃分析。
JAMA. 2008 May 21;299(19):2304-12. doi: 10.1001/jama.299.19.jrv80007. Epub 2008 Apr 28.
8
Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier.生物相容性和可生物降解的聚合物囊泡包裹血红蛋白:一种潜在的氧载体。
Bioconjug Chem. 2008 May;19(5):1025-32. doi: 10.1021/bc700465v. Epub 2008 Apr 29.
9
Inhaled nitric oxide enables artificial blood transfusion without hypertension.吸入一氧化氮可实现无高血压的人工输血。
Circulation. 2008 Apr 15;117(15):1982-90. doi: 10.1161/CIRCULATIONAHA.107.729137. Epub 2008 Apr 7.
10
Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting.多聚血红蛋白-纤维蛋白原:一种在血液稀释环境中具有类似血小板特性的新型氧载体。
Artif Cells Blood Substit Immobil Biotechnol. 2007;35(5):481-9. doi: 10.1080/10731190701586210.